Metamizol is a pyrazolone derivative primarily used as a non-opioid analgesic and antipyretic for the management of moderate to severe pain, including postoperative and acute injury-related pain. Due to… Read more
Metamizol is a pyrazolone derivative primarily used as a non-opioid analgesic and antipyretic for the management of moderate to severe pain, including postoperative and acute injury-related pain. Due to its potent therapeutic properties, ensuring the accuracy of analytical methods for this drug is a vital component of quality control and regulatory compliance. This category provides essential reference standards for Metamizol, including pharmacopeial and non-pharmacopeial impurities and relevant metabolites. Additionally, these offerings include stable isotope labelled compounds, which act as critical internal standards for precise quantification in bioanalytical methods, such as liquid chromatography-mass spectrometry. Pharmaceutical laboratories rely on these high-quality standards to conduct rigorous impurity profiling, validate analytical methods, and monitor drug metabolism, ultimately ensuring that therapeutic formulations maintain the necessary safety and efficacy standards throughout the development and manufacturing processes.